Virtu Financial LLC - PHIO PHARMACEUTICALS CORP ownership

PHIO PHARMACEUTICALS CORP's ticker is PHIO and the CUSIP is 71880W303. A total of 19 filers reported holding PHIO PHARMACEUTICALS CORP in Q2 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of PHIO PHARMACEUTICALS CORP
ValueSharesWeighting
Q3 2022$11,0000.0%19,464
+26.6%
0.00%0.0%
Q2 2022$11,000
-71.1%
15,371
-64.0%
0.00%
-66.7%
Q1 2022$38,000
-24.0%
42,687
-14.0%
0.00%
-40.0%
Q4 2021$50,000
-45.7%
49,643
+9.2%
0.01%
-37.5%
Q3 2021$92,000
+50.8%
45,458
+67.7%
0.01%
+33.3%
Q2 2021$61,000
+45.2%
27,110
+74.7%
0.01%
+100.0%
Q1 2021$42,000
-45.5%
15,522
-56.8%
0.00%
-76.9%
Q3 2020$77,00035,9290.01%
Other shareholders
PHIO PHARMACEUTICALS CORP shareholders Q2 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 40,684$83,0000.01%
Virtu Financial LLC 45,458$92,0000.01%
Total Clarity Wealth Management, Inc. 1,500$3,0000.00%
TWO SIGMA ADVISERS, LP 153,100$311,0000.00%
Cetera Investment Advisers 30,000$61,0000.00%
UBS Group AG 6,241$13,0000.00%
TWO SIGMA INVESTMENTS, LP 42,137$86,0000.00%
BANK OF AMERICA CORP /DE/ 63$00.00%
WELLS FARGO & COMPANY/MN 53$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of PHIO PHARMACEUTICALS CORP shareholders